Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Reductant dosing correction during no dosing periods

US Patent 10801385 · Granted Oct 13, 2020

Estimated economic value: $57,381,000

Assignee

Inventors

View full patent text on Google Patents →